Can the NOS3 rs2070744 CT genotype reduce eNOS expression and nitric oxide availability?

The NOS3 rs2070744 (−786T>C) CT genotype is biologically plausible as a modest contributor to lower endothelial nitric-oxide signaling, not as a deterministic cause of endothelial dysfunction.

Clinical and functional evidence

• The C allele is a functional NOS3 promoter allele with lower transcriptional activity than the T allele. Genotype-stratified findings support an allele-dose pattern: TT generally has higher eNOS mRNA/protein expression, CT is intermediate, and CC is lowest.
• In essential hypertension, C-allele carriers had lower circulating nitrite/nitrate, a surrogate of NO availability; reductions were greater in CC than CT carriers. In hypertensive participants, acetylcholine-mediated forearm dilation was greater in TT than CT/CC groups. In type 2 diabetes, particularly among smokers, flow-mediated dilation was lower in TC/CC than TT individuals.
• These associations are not uniform: a large community study found no association with flow-mediated dilation or hyperemic flow velocity, and some exercise-related findings differed by sex and context.

Mechanistic basis

• The −786C promoter sequence has reduced transcriptional activity, potentially through increased binding of the transcriptional repressor RPA1. Reduced NOS3 transcription can lower eNOS abundance; lower endothelial eNOS expression directly reduces nitric-oxide synthesis/production.
• CT retains one T allele. Accordingly, its expected phenotype is intermediate and generally less pronounced than CC. Under laminar shear stress, CT endothelial cells can retain inducible eNOS mRNA and protein expression, whereas impairment is most marked with CC.

Clinical interpretation

• Smoking, diabetes, hypertension, oxidative stress, sex, vascular bed, medications, and physiologic stimulation can modify whether this genotype translates into measurable NO or vascular-function changes.

Bottom line

• CT can modestly reduce eNOS expression and contribute to lower NO availability relative to TT, but it is a context-dependent susceptibility factor—not evidence of a fixed or large individual deficit.